header-10.jpg
About Us

Mary-Anne Kedda

Mary-Anne Kedda

Positions

  • Clinical Registry Manager
  • Adjunct Associate Professor, School of Population Health, University of Western Australia

Contact Details

Phone
+61 7 3176 7432
Linkedin profile
https://au.linkedin.com/in/maryannekedda

Qualifications

MPH, Epidemiology & Research Methods, Queensland University of Technology, Australia, 2007

PhD, Human Genetics, University of the Witwatersrand, South Africa, 1993

BSc (Hons), Human Genetics, University of the Witwatersrand, South Africa, 1988

Biography

Dr Kedda is the Clinical Registry Manager at the Australian Prostate Cancer Research Centre – Queensland, and an Adjunct Associate Professor at the School of Population Health at the University of Western Australia.  Prior to this appointment, Dr Kedda was the Clinical Trials Manager at the Department of Radiation Oncology at Sir Charles Gairdner Hospital in Perth, Western Australia (WA), which is the largest public provider of Radiation Oncology services in WA.

Dr Kedda is a Molecular Epidemiologist, with a long track record in clinical research of hormone-related cancers, including prostate cancer. She has published internationally in this area and received national funding from the NHMRC and Cancer Australia. She is particularly interested in health-related quality of life, prognostic biomarkers, and the application of good clinical practice in clinical research.

Dr Kedda manages the Queensland node of the Prostate Cancer Outcomes Registry (PCOR-QLD), which has been funded by Movember and is designed to assess patterns of care - and improve the quality of care - for men diagnosed with prostate cancer in Australia.

Awards and grants

Year/Duration

Funding Agency (in full at first  use then abbreviate for subsequent use)

Title

Investigators (Initial Surname)

2015

Sir Charles Gairdner Hospital Research Advisory Grant

Towards participating in the international PACE Study

C Tang, S Bydder, MA Kedda

2013

Cancer Australia

Piloting of a Prostate Cancer Data Set Specification

T Shannon, MA Kedda

2013

Radiation Oncology Small Grants Scheme

WA Radiation Oncology: Strategic Data Management

A Yahya, MA Kedda, V Antoff, R Budge

2006-2008

NHMRC

Kallikrein gene variants in prostate cancer: analysis of gene regulation and diagnostic/prognostic use

MA Kedda, AB Spurlde, JA Clements

Research interests

Prostate cancer, clinical registry, prognostic biomarkers, quality of life

Current research projects

Manager: Prostate Cancer Outcomes Registry – Queensland (PCOR-QLD)

Team

  1. Alexander KE, Chamers S, Spurdle AB, Batra J, Lose F, O’Mara T, Gardiner RA, Aitken JF, Clements JA, Kedda MA, Janda M. Association between single nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population. Qual Life Res. 2015; Feb 28 (Epub).
  2. Batra J, Lose F, O'Mara T, Marquart L, Stephens C, Alexander K, Srinivasan S, Eeles RA, Easton DF, Al Olama AA, Kote-Jarai Z, Guy M, Muir K, Lophatananon A, Rahman AA, Neal DE, Hamdy FC, Donovan JL, Chambers S, Gardiner RA, Aitken J, Yaxley J, Kedda MA, Clements JA, Spurdle AB. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data. PLoS One. 2011;6(11):e26527. Epub 2011 Nov 23.
  3. Lose F, Batra J, O'Mara T, Fahey P, Marquart L, Eeles RA, Easton DF, Al Olama AA, Kote-Jarai Z, Guy M, Muir K, Lophatananon A, Rahman AA, Neal DE, Hamdy FC, Donovan JL, Chambers S, Gardiner RA, Aitken JF, Yaxley J, Alexander K, Clements JA, Spurdle AB, Kedda MA; Australian Prostate Cancer BioResource. Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. Urol Oncol. 2013; 31:635-43.
  4. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dörk T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer  EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, FitzGerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet. 2009 Oct;41(10):1116-21.
  5. Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D, Donovan J, Hamdy F, Cox A, Maier C, Vogel W, Guy M, Muir K, Lophatananon A, Kedda MA, Spurdle A, Steginga S, John EM, Giles G, Hopper J, Chappuis PO, Hutter P, Foulkes WD, Hamel N, Salinas CA, Koopmeiners JS, Karyadi DM, Johanneson B, Wahlfors T, Tammela TL, Stern MC, Corral R, McDonnell SK, Schürmann P, Meyer A, Kuefer R, Leongamornlert DA, Tymrakiewicz M, Liu JF, O'Mara T, Gardiner RA, Aitken J, Joshi AD, Severi G, English DR, Southey M, Edwards SM, Al Olama AA; PRACTICAL Consortium, Eeles RA. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2052-61. Erratum in: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2901.

 

Professional memberships and associations

Year

Title, Organisation

2011-present

Trans Tasman Radiation Oncology Group (TROG)

2011-present

Clinical Oncological Society of Australia (COSA)

2011-present

Society of Clinical Research Associates (SOCRA, USA)

2006-present

Australian Epidemiological Association

2002-present

American Association of Cancer Research (AACR)

2002-present

Australian Society for Medical Research (ASMR)

1998-present

Human Genetics Society of Australasia (HGSA)